Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Takeshi Aoyama

The Cancer Institute Hospital

Japan

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

30%

Pharmacology

20%

Adverse Drug Reaction

30%

Oncology

20%

Chemotherapy

20%

Pharmacokinetic

10%

Graft-versus-host Disease

10%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles5

Safety evaluation of fixed‐dose nivolumab in patients with gastric cancer

Article Link

Year:

2022

Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers

Article Link

Year:

2021

Comparison of cisplatin-induced nephrotoxicity when using conventional versus short hydration in gastric cancer—a retrospective study

Article Link

Year:

2020

Impact of Primary Pegfilgrastim Prophylaxis on Relative Dose Intensity in Neoadjuvant/Adjuvant FEC-100 Chemotherapy.

Article Link

Year:

2020

Association of Immune-Related Adverse Events with Pembrolizumab Efficacy in the Treatment of Advanced Urothelial Carcinoma.

Article Link

Year:

2020

Collaborators2

takashi yokokawa

Cancer Institute Hospital of Japanese Foundation for Cancer Research

JAPAN

Hitoshi Sato

Professor

Showa University

JAPAN

How do I reach out?

Meet Kite AI